Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Distal 17p13.3 microdeletion syndrome is a rare partial monosomy of the short arm of chromosome 17 with a variable phenotype characterized by prenatal and postnatal growth retardation, developmental delay, mild intellectual disability, macrocephaly, mild facial dysmorphisms including prominent forehead, hypertelorism, thick upper and/or lower lip vermillion, and structural abnormalities of the brain variably including white matter abnormalities, prominent Virchow-Robin spaces, Chiari I malformation, corpus callosum hypoplasia, but no lissencephaly.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for distal 17p13.3 microdeletion syndrome.
2 publications have been identified in PubMed for distal 17p13.3 microdeletion syndrome. Research spans Review / Meta-Analysis (100%).
van Kampen F (2025). [PMID: 39966556](https://pubmed.ncbi.nlm.nih.gov/39966556/). *Oncogene*. [Review / Meta-Analysis]
Ji X (2025). [PMID: 40390087](https://pubmed.ncbi.nlm.nih.gov/40390087/). *BMC Med Genomics*. [Review / Meta-Analysis]
Data assembled from 3 of 12 sources · Last updated Sep 20, 2026, 11:13 AM UTC
European rare disease database
Genetic and Rare Diseases Info Center